Skip to main content
Clinical Trials/KCT0002945
KCT0002945
Recruiting
N/A

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

Asan Medical Center0 sites140 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Asan Medical Center
Enrollment
140
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1Age 18 years or older
  • 2Patients experienced successfully resuscitated cardiac arrest due to documented ventricular fibrillation or sustained rapid ventricular tachycardia within 6 months of randomization
  • 3Normal on coronary angiogram as no evidence of \=50% stenosis or ischemic lesion and diagnosed as variant angina which is defined by spontaneous coronary spasm with ST elevation (\=0\.1mV) or \=90% of lumen loss in the coronary angiogram on ergonovine provocation coronary angiography
  • 4Patent or legal representative agrees to the trial protocol and follow\-up surveillence and provides written informed consent on IRB/EC approved template

Exclusion Criteria

  • 1Significant (\>50%) coronary artery stenosis on coronary angiography
  • 2Organic heart disease known to be associated with sudden cardiac arrest.
  • \-          Heart failure with reduced ejection fraction (LV EF \< 35%)
  • \-          Presence of LV akinesia or aneurysm
  • \-          Hypertrophic cardiomyopathy
  • \-          Arrhythmogenic right ventricular dysplasia
  • 3CHF New York Heart Association functional class III or IV
  • 4prior history of atrial or ventricular arrhythmia requiring class I or III antiarrhythmic drugs (flecainide, propafenone, amiodarone, sotalol and dronedarone)
  • 5Primary cardiac electrical diseases (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia)
  • 6Prior pacemaker or Implantable Cardioverter Defibrillator (ICD)

Outcomes

Primary Outcomes

Not specified

Similar Trials